García Verdecia B.
135
Coauthors
12
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2003 | 1 |
2008 | 2 |
2009 | 1 |
2011 | 1 |
2013 | 1 |
2015 | 1 |
2016 | 2 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Cáncer | 14 |
Inmunología | 9 |
Medicina interna | 1 |
Medicamento | 1 |
Ingeniería de manufactura | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Enfermedades | 10 |
Farmacología y terapéutica | 5 |
Fisiología humana | 2 |
Medicina y salud | 1 |
Grupos de personas | 1 |
Bioquímica | 1 |
Física aplicada | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 12 |
Google Scholar | 0 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
Tania Crombet | 12 |
Lage Davila A. | 9 |
Neninger Vinageras E. | 9 |
Mazorra Z. | 7 |
Luaces P.L.o. | 6 |
González G. | 5 |
Rodríguez P.C. | 4 |
Carmen Elena Viada | 4 |
Popa X. | 4 |
González A. | 4 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
ReviewAbstract: Epidermal growth factor receptor (EGFR) is overexpressed in many epithelial tumors and its role in tPalabras claves:cancer vaccine, clinical trials, Epidermal growth factor, Epidermal growth factor receptor, lung cancer, Non-small-cell lung cancerAutores:García Verdecia B., Lage Davila A., Neninger Vinageras E., Rodríguez P.C., Tania CrombetFuentes:scopusImmunosenescence and gender: A study in healthy Cubans
ArticleAbstract: Background: The progressive decline in the immune function during ageing is termed immunosenescence.Palabras claves:Autores:de Jesús Badía Alvarez T., García Verdecia B., Lage Davila A., Leonard Rupalé I., Luaces P.L.o., Mazorra Z., Saavedra Hernández D., Tania CrombetFuentes:scopusCIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer
ArticleAbstract: The results allowing the Cuban Regulatory Agency (CECMED) to grant the Sanitary Registration to thePalabras claves:cancer vaccine, CIMAvax-EGF, Fast-Track registration, NSCLC, Phase II-III clinical trialAutores:Arteaga N., Cuevas A., García Verdecia B., González G., Lage Davila A., Neninger Vinageras E., Rodríguez G., Tania Crombet, Viña L.Fuentes:scopusBiomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
ArticleAbstract: Purpose: There are well-known alterations occurring within the immune system with aging. CollectivelPalabras claves:cancer vaccine, Immunosenescence, Immunosenescence markers, Non-small cell lung cancerAutores:Fuentes K.P., García Verdecia B., González A., Lage Davila A., Luaces P.L.o., Mazorra Z., Neninger Vinageras E., Popa X., Saavedra Hernández D., Tania CrombetFuentes:scopusEffective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine
ArticleAbstract: Purpose: Epidermal growth factor (EGF) might be a suitable immunotherapeutic target in non-small-celPalabras claves:Autores:Carmen Elena Viada, De La Torre A.V., García Verdecia B., González G., Lage Davila A., Leonard I., Martínez R., Mazorra Z., Neninger Vinageras E., Tania CrombetFuentes:scopus